Showing 1 - 10 of 10
Intelligent energy services often are enabled by the capabilities inherent in energy infrastructure. Potential capacity capabilities include security, reliability, resilience, and sustainability. These capabilities can change the dynamics of energy markets, stimulating additional demand and...
Persistent link: https://www.econbiz.de/10012501672
Persistent link: https://www.econbiz.de/10003744229
Pacific Life is a diversified financial services company with a history of autonomous business units. Pacific Life had five independent divisions, including Life Insurance, Annuities and Mutual Funds, and Investments. These divisions served different customers and responded to different...
Persistent link: https://www.econbiz.de/10003948607
Large engineering projects (LEPs) are high-stakes games characterized by substantial irreversible commitments, skewed reward structures when they are successful, and high probabilities of failure. Their dynamics also change over time. The journey from initial conception to ramp-up and revenue...
Persistent link: https://www.econbiz.de/10003948739
Persistent link: https://www.econbiz.de/10009489386
This chapter explores the uncertainties associated with today's highly interdependent supply chains and the risks inherent their geographic dispersion and organizational fragmentation. It first lays out the sources of risk and their potential consequences to the corporations who are supply chain...
Persistent link: https://www.econbiz.de/10010194978
Persistent link: https://www.econbiz.de/10003745759
Persistent link: https://www.econbiz.de/10012012161
Urban Mobility is in the midst of a revolution, driven by the convergence of technologies such as artificial intelligence, on-demand ride services, as well as connected and self-driving vehicles. Technological advancements often lead to new hazards and changing nature in how accidents can...
Persistent link: https://www.econbiz.de/10012012212
The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...
Persistent link: https://www.econbiz.de/10011749446